Ultramodern GMP plant for the production of therapeutic monoclonal antibodies (mAbs)
Flexible multi-product plant
Manufacturing capability comprising dual 2,000L bioreactors based on single-use technologies
Old city, young vibe
Byondis is headquartered in the oldest city of the Netherlands: Nijmegen
We are proud to be part of this vibrant and growing city. Long history, exciting future!
Solid roots
Byondis is the largest Dutch-owned biotechnology company in the Netherlands.
We are a privately-owned business with an entrepreneurial staff sharing ambitious goals. As our Founder and Chairman, Jacques Lemmens, puts it, “We want to build a company in a beautiful way, with beautiful results, beautiful products.”
25 nationalities sharing 1 goal
At Byondis we are represented with over 25 nationalities with employees speaking over 15 different languages.
Our company brings people together from many different backgrounds, countries and cultures. At Byondis our strength lies in differences, not in similarities. We believe all our employees have something unique and innovative to contribute to our collective goal of outsmarting cancer.
State-of-the-art
The Byondis campus houses state-of-the art research and development facilities.
Unlike many other mid-sized biotech companies, we have in-house good manufacturing practice (GMP) manufacturing and conjugation facilities for both mAbs and ADCs, right up to early commercial launch scale.
Monoclonal Antibody Plant
Antibody-drug Conjugation Facility
The facility includes a high-potent clean room suite and supporting areas for buffer preparation and in-process control testing
Inspected and approved by the Dutch authorities for manufacturing and release of ADC material and Investigational Medicinal Product for use in clinical programs
Main R&D Building
2,000 m2 of laboratory space
2,400 m2 office space, housing the majority of Byondis’ R&D staff
800 m2 GMP warehouse
